Original Research
Accepted on 23 Feb 2026
Riboflavin (VB2) Inhibits Hepatocellular Carcinogenesis by Enhancing Retinol Metabolism and Suppressing Cell Proliferation in Hras12V Transgenic Mice
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
